Brazil's industry leaders promise new impetus
This article was originally published in Clinica
Executive Summary
A new stage in the evolution of Brazil's medical technology arena is afoot, with the appointment of new presidents at industry associations ABIMO and SINAEMO (which represents the sector's healthcare-political interests). Their key aims are to promote better access to medtech, in line with the federal government's healthcare priorities, and to work towards meeting up to 95% of the US$3.2bn market's needs from domestic manufacturing.